Kenneth Bate
Chief Financial Officer, NITROMED INC.
Companies
- MADRIGAL PHARMACEUTICALS, INC.Board member Jul 29, 2016 to now1
- Catabasis PharmaceuticalsBoard member Jun 24, 2015 to now2
- AVEO PHARMACEUTICALS, INC.Board member Mar 11, 2010 to Jan 19, 20233
- Epizyme, Inc.Board member Dec 12, 2014 to Aug 16, 20224
- Genocea (United States)Board member Sep 15, 2014 to Jul 2, 20215
- Vanda Pharmaceuticals Inc.Board member Dec 21, 2015 to Jun 19, 20176
- BioMarin PharmaceuticalBoard member Sep 24, 2010 to Jun 18, 20157
- Cubist PharmaceuticalsBoard member Jun 9, 2006 to Jan 21, 20158
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- MADRIGAL PHARMACEUTICALS, INC. MDGL2,627 shares9$1.2M at $459.81Nov 5, 2025
- AVEO PHARMACEUTICALS, INC.375 shares10Jan 19, 2023
- Epizyme, Inc.0 shares11Aug 12, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 5, 2025Sold 30 shares at $490.98 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Sold 933 shares at $489.95 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Sold 696 shares at $489.09 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Sold 2,775 shares at $487.49 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Sold 827 shares at $486.73 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Sold 1,008 shares at $485.54 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Sold 1,931 shares at $484.78 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Sold 2,069 shares at $483.41 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Sold 1,284 shares at $482.41 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Sold 3,259 shares at $481.13 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Sold 1,763 shares at $480.24 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Exercised options 1,105 shares at $280.04 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Exercised options 10,000 shares at $303.79 of MADRIGAL PHARMACEUTICALS, INC.9
- Nov 5, 2025Exercised options 5,470 shares at $9.45 of MADRIGAL PHARMACEUTICALS, INC.9
- Aug 15, 2025Sold 896 shares at $368.56 of MADRIGAL PHARMACEUTICALS, INC.12
- Aug 15, 2025Sold 1,104 shares at $367.63 of MADRIGAL PHARMACEUTICALS, INC.12
- Aug 15, 2025Sold 600 shares at $366.14 of MADRIGAL PHARMACEUTICALS, INC.12
- Aug 15, 2025Sold 2,567 shares at $365.33 of MADRIGAL PHARMACEUTICALS, INC.12
- Aug 15, 2025Sold 2,516 shares at $364.24 of MADRIGAL PHARMACEUTICALS, INC.12
- Aug 15, 2025Sold 2,317 shares at $363.41 of MADRIGAL PHARMACEUTICALS, INC.12
- Aug 15, 2025Exercised options 10,000 shares at $16.46 of MADRIGAL PHARMACEUTICALS, INC.12
- Jun 20, 2025Granted 715 shares of MADRIGAL PHARMACEUTICALS, INC.13
- Feb 27, 2025Sold 216 shares at $360.07 of MADRIGAL PHARMACEUTICALS, INC.14
- Feb 27, 2025Sold 2,024 shares at $359.21 of MADRIGAL PHARMACEUTICALS, INC.14
- Feb 27, 2025Sold 3,548 shares at $358.33 of MADRIGAL PHARMACEUTICALS, INC.14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGAREpizyme, Inc., Board member
- 5
- 6
- 7
- 8SEC EDGARCubist Pharmaceuticals, Board member
- 9
- 10
- 11
- 12SEC EDGARForm 4 filed Aug 15, 2025
- 13SEC EDGARForm 4 filed Jun 24, 2025
- 14SEC EDGARForm 4 filed Feb 28, 2025